[Therapeutic aspects of Wegener's granulomatosis].
Kettritz
R
R
I. Medizinische Klinik, Klinikums Berlin-Buch.
Göbel
U
U
Laske
H R
HR
Müller
V
V
Bohnenkamp
M
M
Schneider
W
W
Natusch
R
R
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003131:Combined Modality Therapy; D003404:Creatinine / Q000097:blood; D003520:Cyclophosphamide / Q000008:administration & dosage*; D016572:Cyclosporine / Q000008:administration & dosage; D005260:Female; D014890:Granulomatosis with Polyangiitis / Q000401:mortality / Q000628:therapy*; D006801:Humans; D007674:Kidney Diseases / Q000401:mortality / Q000628:therapy*; D008171:Lung Diseases / Q000401:mortality / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010956:Plasmapheresis; D011239:Prednisolone / Q000008:administration & dosage; D012189:Retrospective Studies; D015996:Survival Rate; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000008:administration & dosage*
D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D016572:Cyclosporine; D003520:Cyclophosphamide; D011239:Prednisolone; D003404:Creatinine
Therapeutische Aspekte der Wegenerschen Granulomatose.